Neuropathological Considerations in Management of Deep-Seated Gliomas

  • Peter C. Johnson
Part of the Contemporary Perspectives in Neurosurgery book series (COPENEU)


Simultaneous developments in microneurosurgical techniques, neuroradiology, and neuropathology offer hope that in the future effective treatment strategies may be developed for a disease currently with a poor prognosis—deep-seated glial tumors of the brain. The purpose of this report is to communicate our recent findings from a study that utilized a newly developed technique involving magnetic resonance imaging (MRI), followed by pathological analysis, of postmortem brain specimens harboring these neoplasms.1 I will discuss our results in light of current and prior related studies and then postulate possible future avenues for study.


Attenuation Hunt Meningioma Reso Astrocytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Johnson PC, Hunt SS, Drayer BP: Correlation of postmortem magnetic resonance and neuropathology in human gliomas. Radiology, 1989; 170: 211–217.PubMedGoogle Scholar
  2. 2.
    Holland BA, Zawadzki-Brant M, Norman D, et al: Magnetic resonance imaging of primary intracranial tumors: a review. J Radiat Oncol Biol Physiol 1985; 11 (2): 315–321.CrossRefGoogle Scholar
  3. 3.
    Awad IA, Johnson PC, Spetzler RF, et al: Incidental subcortical lesions identified on magnetic resonance imaging in the elderly: II. Postmortem pathology correlations. Stroke 1986; 17: 1090–1097.PubMedCrossRefGoogle Scholar
  4. 4.
    Burger PC: Pathologic anatomy and CT correlations in the glioblastoma multiforme. Appl Neurophysiol 1983; 46: 180–186.PubMedGoogle Scholar
  5. 5.
    Burger PC, Dubois PJ, Schold SC Jr, et al: Computerized tomographic and pathological studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 1983; 58: 159–169.PubMedCrossRefGoogle Scholar
  6. 6.
    Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 1980; 30: 907–911.PubMedCrossRefGoogle Scholar
  7. 7.
    Lilja A, Bergstrom K, Spannare B, et al: Reliability of computed tomography in assessing histopathological features of malignant supratentorial gliomas. J Comput Assist Tomogr 1981; 5 (5): 625–636.PubMedGoogle Scholar
  8. 8.
    Kelly PJ, Daumas-Duport C, Scheithauer BW, et al: Stereotactic histologic correlations of computed tomography-and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987; 62: 450–459.PubMedGoogle Scholar
  9. 9.
    Kelly PJ, Earnest E IV, Kall B, et al: Surgical options for patients with deep-seated brain tumors: computer assisted stereotactic biopsy. Mayo Clin Proc 1985; 60: 223–229.PubMedGoogle Scholar
  10. 10.
    Scherer HJ: The forms of growth in gliomas and their practical significance. Brain 1940; 63: 1–35.CrossRefGoogle Scholar
  11. 11.
    Daumas-Duport C, Monsaingeon V, N’Guyen JP, et al: Some correlations between histological and CT aspects of cerebral gliomas contributing to the choice of significant trajectories for stereotactic biopsies. Acta Neurochir Suppl 1984; 33: 185–194.Google Scholar
  12. 12.
    Daumas-Duport C, Monsaingeon V, Szenthe L, et al: Serial stereotactic biopsies: a double histological code of gliomas according to malignancy and 3-D configuration, as an aid to therapeutic decision and assessment of results. Appl Neurophysiol 1982; 45: 431–437.PubMedGoogle Scholar
  13. 13.
    Daumas-Duport C, Scheithauer BW, Kelly PJ: A histological and cytologic method for the spatial definition of gliomas. Mayo Clin Proc 1987; 62: 435–449.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Peter C. Johnson
    • 1
  1. 1.Department of NeuropathologyBarrow Neurological InstitutePhoenixUSA

Personalised recommendations